BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanes MS, Salanga CL, Chowdry AB, Comerford I, McColl SR, Kufareva I, Handel TM. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines. J Biol Chem 2015;290:22385-97. [PMID: 26216880 DOI: 10.1074/jbc.M115.675108] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Pance K, Gramespacher JA, Byrnes JR, Salangsang F, Serrano JC, Cotton AD, Steri V, Wells JA. Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. Nat Biotechnol 2022. [PMID: 36138170 DOI: 10.1038/s41587-022-01456-2] [Reference Citation Analysis]
2 Pollak AJ, Zhao L, Vickers TA, Huggins IJ, Liang XH, Crooke ST. Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. Nucleic Acids Res 2022:gkac618. [PMID: 35848907 DOI: 10.1093/nar/gkac618] [Reference Citation Analysis]
3 Yen Y, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias. Sci Adv 2022;8:eabn8063. [DOI: 10.1126/sciadv.abn8063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Heng AHS, Han CW, Abbott C, McColl SR, Comerford I. Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease. Front Immunol 2022;13:817473. [PMID: 35250997 DOI: 10.3389/fimmu.2022.817473] [Reference Citation Analysis]
5 Eberle SA, Gustavsson M. A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine–Chemokine Receptor Interactions. Cells 2022;11:1317. [DOI: 10.3390/cells11081317] [Reference Citation Analysis]
6 Uricoli B, Birnbaum LA, Do P, Kelvin JM, Jain J, Costanza E, Chyong A, Porter CC, Rafiq S, Dreaden EC. Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy. Adv Healthc Mater 2021;10:e2002214. [PMID: 33690997 DOI: 10.1002/adhm.202002214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Lai WY, Mueller A. Latest update on chemokine receptors as therapeutic targets. Biochem Soc Trans 2021;49:1385-95. [PMID: 34060588 DOI: 10.1042/BST20201114] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Rosenberg EM Jr, Herrington J, Rajasekaran D, Murphy JW, Pantouris G, Lolis EJ. The N-terminal length and side-chain composition of CXCL13 affect crystallization, structure and functional activity. Acta Crystallogr D Struct Biol 2020;76:1033-49. [PMID: 33021505 DOI: 10.1107/S2059798320011687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Stephens BS, Ngo T, Kufareva I, Handel TM. Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis. Sci Signal 2020;13:eaay5024. [PMID: 32665413 DOI: 10.1126/scisignal.aay5024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jaracz-Ros A, Bernadat G, Cutolo P, Gallego C, Gustavsson M, Cecon E, Baleux F, Kufareva I, Handel TM, Bachelerie F, Levoye A. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors. J Leukoc Biol 2020;107:1123-35. [PMID: 32374043 DOI: 10.1002/JLB.2MA0320-383RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhu S, Min Z, Qiao X, Chen S, Yang J, Zhang X, Liu X, Ran W, Lv R, Lin Y, Wang J. Expression profile-based screening for critical genes reveals S100A4, ACKR3 and CDH1 in docetaxel-resistant prostate cancer cells. Aging (Albany NY) 2019;11:12754-72. [PMID: 31895690 DOI: 10.18632/aging.102600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
12 Quinn KE, Mackie DI, Caron KM. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology. Cytokine 2018;109:17-23. [PMID: 29903572 DOI: 10.1016/j.cyto.2018.02.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
13 Gustavsson M, Dyer DP, Zhao C, Handel TM. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding. Sci Signal 2019;12:eaaw3657. [PMID: 31506383 DOI: 10.1126/scisignal.aaw3657] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
14 García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases. Front Endocrinol (Lausanne) 2019;10:585. [PMID: 31507535 DOI: 10.3389/fendo.2019.00585] [Cited by in Crossref: 40] [Cited by in F6Publishing: 56] [Article Influence: 13.3] [Reference Citation Analysis]
15 Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. Br J Pharmacol 2018;175:1419-38. [PMID: 29272550 DOI: 10.1111/bph.14132] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
16 Zheng Y, Han GW, Abagyan R, Wu B, Stevens RC, Cherezov V, Kufareva I, Handel TM. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV. Immunity 2017;46:1005-1017.e5. [PMID: 28636951 DOI: 10.1016/j.immuni.2017.05.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 19.0] [Reference Citation Analysis]
17 Kufareva I, Gustavsson M, Zheng Y, Stephens BS, Handel TM. What Do Structures Tell Us About Chemokine Receptor Function and Antagonism? Annu Rev Biophys 2017;46:175-98. [PMID: 28532213 DOI: 10.1146/annurev-biophys-051013-022942] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
18 Benredjem B, Girard M, Rhainds D, St-Onge G, Heveker N. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12. J Biol Chem 2017;292:31-42. [PMID: 27875312 DOI: 10.1074/jbc.M116.762252] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
19 Pacitto R, Gaeta I, Swanson JA, Yoshida S. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages. J Leukoc Biol 2017;101:683-92. [PMID: 28250113 DOI: 10.1189/jlb.2A0316-141RR] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
20 Wescott MP, Kufareva I, Paes C, Goodman JR, Thaker Y, Puffer BA, Berdougo E, Rucker JB, Handel TM, Doranz BJ. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices. Proc Natl Acad Sci U S A 2016;113:9928-33. [PMID: 27543332 DOI: 10.1073/pnas.1601278113] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 10.8] [Reference Citation Analysis]
21 Kufareva I. Chemokines and their receptors: insights from molecular modeling and crystallography. Curr Opin Pharmacol 2016;30:27-37. [PMID: 27459124 DOI: 10.1016/j.coph.2016.07.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
22 Kleist AB, Getschman AE, Ziarek JJ, Nevins AM, Gauthier PA, Chevigné A, Szpakowska M, Volkman BF. New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Biochem Pharmacol 2016;114:53-68. [PMID: 27106080 DOI: 10.1016/j.bcp.2016.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]